Early detection of cancer.


The AlphaLiquid® platform enables enhanced safety,
speed and efficiency in clinical trials for drug development

Key Value Proposition

  • · Customized panel design services to fulfill clinical development needs
  • · Extensive oncology clinical network in Korea
  • · Professional support from IMBdx medical, R&D and bioinformatics teams
  • · Industry leading assay performance at competitive prices
  • · Dedicated project manager for personalized real-time services

Biopharma Collaborations

Case 1 – Overseas Client C, AlphaLiquid® 100 Platform + Spike-In of genes requested by client = Customized CDx panel Development for Phase Ⅱ/Ⅲ global trials Case 2 – Overseas Client A, AlphaLiquid® HRR platform = Development of HRR gene panel as a liquid biopsy companion diagnostic for LYNPARZA (Olaparib) in prostate cancer patients
Case 2 - Domestic Client A, AlphaLiquid® 500 Platform = Biomarker discovery and efficacy testing